{"disease":{"id":"patients-with-prostate-cancer","name":"patients with prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05009290","title":"A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":391,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06970847","title":"64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Clarity Pharmaceuticals Ltd","has_results":false},{"nct_id":"NCT04835454","title":"Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03527199","title":"Prostate Cancer Patients With Biochemical Recurrence","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Medhat Osman","has_results":false},{"nct_id":"NCT06500247","title":"Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":43,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06136377","title":"Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Centre Georges Francois Leclerc","has_results":false},{"nct_id":"NCT06972628","title":"Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Ebrahim S Delpassand","has_results":false},{"nct_id":"NCT04712396","title":"A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}